Clenpiq Alternatives Compared
| Clenpiq (citric acid/magnesium oxide/sodium picosulfate) | MiraLAX (polyethylene glycol 3350) | Polyethylene glycol 3350 |
|
|---|
| Clenpiq (citric acid/magnesium oxide/sodium picosulfate) | MiraLAX (polyethylene glycol 3350) | Polyethylene glycol 3350 |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Bowel Preparation. Clenpiq may also be used for purposes not listed in this medication guide. |
Prescription and OTC
Prescribed for Irritable Bowel Syndrome with Constipation, Bowel Preparation, Constipation - Acute, Constipation, Irritable Bowel Syndrome. MiraLAX may also be used for purposes not listed in this... View more |
Prescription and OTC
Prescribed for Irritable Bowel Syndrome with Constipation, Bowel Preparation, Constipation - Acute, Constipation, Irritable Bowel Syndrome. Polyethylene glycol 3350 may also be used for purposes not... View more |
Related suggestions |
|||||||||||||||
| More about Clenpiq (citric acid/magnesium oxide/sodium picosulfate) | More about MiraLAX (polyethylene glycol 3350) | More about Polyethylene glycol 3350 | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Clenpiq has an average rating of 6.0 out of 10 from a total of 305 ratings on Drugs.com. 49% of reviewers reported a positive effect, while 37% reported a negative effect. |
MiraLAX has an average rating of 7.2 out of 10 from a total of 262 ratings on Drugs.com. 65% of reviewers reported a positive effect, while 23% reported a negative effect. |
Polyethylene glycol 3350 has an average rating of 7.1 out of 10 from a total of 348 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 23% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
View all Clenpiq side effects |
View all MiraLAX side effects |
|||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
Lower cost generic |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all MiraLAX prices |
View all Polyethylene glycol 3350 prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
|
N/A |
Other polyethylene glycol 3350 brands include: ClearLax, GaviLAX, Gialax, GlycoLax, HealthyLax, PEG3350, Purelax, SunMark ClearLax | ClearLax, GaviLAX, Gialax, GlycoLax, HealthyLax, MiraLAX, PEG3350, Purelax, SunMark ClearLax View more | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 661 drugs are known to interact with Clenpiq:
|
A total of 222 drugs are known to interact with MiraLAX:
|
A total of 222 drugs are known to interact with Polyethylene glycol 3350:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
February 18, 1999 |
N/A |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.